FBT vs. XPH
FBT (First Trust Amex Biotechnology Index) and XPH (SPDR S&P Pharmaceuticals ETF) are both Health & Biotech Equities funds - FBT tracks the NYSE Arca Biotechnology Index while XPH tracks the S&P Pharmaceuticals Select Industry Index. Both are passively managed. Over the past 10 years, FBT returned 8.86%/yr vs 3.44%/yr for XPH. A 0.76 correlation means they provide meaningful diversification when combined. FBT charges 0.57%/yr vs 0.35%/yr for XPH.
Performance
FBT vs. XPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FBT achieves a 7.08% return, which is significantly higher than XPH's 0.66% return. Over the past 10 years, FBT has outperformed XPH with an annualized return of 8.86%, while XPH has yielded a comparatively lower 3.44% annualized return.
FBT
- 1D
- 2.92%
- 1M
- 6.19%
- YTD
- 7.08%
- 6M
- 3.95%
- 1Y
- 35.94%
- 3Y*
- 12.40%
- 5Y*
- 6.79%
- 10Y*
- 8.86%
XPH
- 1D
- 1.10%
- 1M
- -4.74%
- YTD
- 0.66%
- 6M
- 4.44%
- 1Y
- 37.98%
- 3Y*
- 13.07%
- 5Y*
- 3.50%
- 10Y*
- 3.44%
FBT vs. XPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 7.08% | 24.25% | 5.88% | 2.55% | -4.83% | -2.26% | 12.96% | 19.74% | -0.30% | 37.07% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 31.60% | 4.94% | 2.97% | -9.83% | -10.54% | 14.68% | 25.61% | -15.32% | 12.05% |
Correlation
The correlation between FBT and XPH is 0.71, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.71 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.74 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.77 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.77 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2006 | 0.76 |
The correlation between FBT and XPH has been stable across timeframes, ranging from 0.71 to 0.77 - a consistent structural relationship.
FBT vs. XPH - Sectors Allocation Comparison
Sectors
FBT
XPH
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT
XPH
Basic Materials
FBT
-
XPH
-
Communication Services
FBT
-
XPH
-
Consumer Cyclical
FBT
-
XPH
-
Consumer Defensive
FBT
-
XPH
-
Energy
FBT
-
XPH
-
Financial Services
FBT
-
XPH
-
Industrials
FBT
-
XPH
-
Real Estate
FBT
-
XPH
-
Technology
FBT
-
XPH
-
Utilities
FBT
-
XPH
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT vs. XPH — Risk / Return Rank
FBT
XPH
FBT vs. XPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT | XPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.04 | ||
| Sortino ratioReturn per unit of downside risk | +0.05 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.30 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 2.53 | 3.19 | -0.66 |
| Martin ratioReturn relative to average drawdown | 7.43 | 11.37 | -3.95 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBT | XPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.74 | 1.77 | -0.04 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.17 | +0.14 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.37 | 0.16 | +0.22 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.38 | +0.13 |
Drawdowns
FBT vs. XPH - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for FBT and XPH.
Loading charts...
Drawdown Indicators
| FBT | XPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -48.03% | +7.52% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -11.97% | -2.29% |
Max Drawdown (3Y)Largest decline over 3 years | -20.05% | -23.57% | +3.52% |
Max Drawdown (5Y)Largest decline over 5 years | -29.05% | -31.63% | +2.58% |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | -35.97% | +3.60% |
Current DrawdownCurrent decline from peak | -0.72% | -7.22% | +6.50% |
Average DrawdownAverage peak-to-trough decline | -11.17% | -17.25% | +6.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.85% | 3.35% | +1.50% |
Volatility
FBT vs. XPH - Volatility Comparison
First Trust Amex Biotechnology Index (FBT) and SPDR S&P Pharmaceuticals ETF (XPH) have volatilities of 6.94% and 7.03%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT | XPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.94% | 7.03% | -0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 15.87% | 16.77% | -0.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.79% | 21.52% | -0.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.89% | 20.84% | +1.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.91% | 22.10% | +1.81% |
FBT vs. XPH - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than XPH's 0.35% expense ratio.
Dividends
FBT vs. XPH - Dividend Comparison
FBT has not paid dividends to shareholders, while XPH's dividend yield for the trailing twelve months is around 0.66%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
XPH SPDR S&P Pharmaceuticals ETF | 0.66% | 0.83% | 1.58% | 1.28% | 1.64% | 0.95% | 0.47% | 0.64% | 0.65% | 0.67% | 0.63% | 7.15% |
Frequently Asked Questions
FBT and XPH have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XPH has higher volatility (7.03%) compared to FBT (6.94%). In terms of maximum drawdown, FBT dropped -40.51% vs XPH's -48.03%.
On 10-year performance, FBT leads with 8.86% vs 3.44% for XPH. On fees, XPH is cheaper at 0.35% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FBT has performed better with a 8.86% return vs 3.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XPH is cheaper with a 0.35% expense ratio, compared with 0.57% for FBT.
XPH has the higher dividend yield at 0.66%, compared with 0.00% for FBT.
FBT tracks NYSE Arca Biotechnology Index, while XPH tracks S&P Pharmaceuticals Select Industry Index. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.57% for FBT and 0.35% for XPH.
XPH currently has the higher Sharpe Ratio (1.77 vs 1.74), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FBT and XPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer